WELLS FARGO & COMPANY/MN - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 15 filers reported holding INHIBIKASE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$759
+1016.2%
1,153
+747.8%
0.00%
Q4 2022$68136
+3.0%
0.00%
Q3 2022$0132
-0.8%
0.00%
Q2 2022$0133
+9.0%
0.00%
Q1 2022$01220.0%0.00%
Q4 2021$01220.0%0.00%
Q3 2021$0122
+916.7%
0.00%
Q2 2021$0120.0%0.00%
Q1 2021$0120.00%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 1,010,000$1,919,0001.00%
Murchinson Ltd. 320,947$610,0000.30%
SABBY MANAGEMENT, LLC 425,014$808,0000.11%
Kepos Capital LP 700,000$1,330,0000.09%
Antara Capital LP 303,000$576,0000.04%
ZEKE CAPITAL ADVISORS, LLC 93,800$178,0000.01%
Warberg Asset Management LLC 26,000$49,0000.01%
Shay Capital LLC 20,000$38,0000.01%
WELLS FARGO & COMPANY/MN 122$00.00%
NORTHERN TRUST CORP 15,714$30,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders